INVA

NASD Innoviva, Inc.
Oct 9, 2026 · 9:05 PM ET EOD Market Closed

$21.21 ↑ +0.00 (+0.00%) Trading Up from the previous close of $21.21, $0.07 below the day’s high of $21.28

YTD change
+6.10%
vs 20-day SMA
+1.62%
vs 200-day SMA
-2.62%

Price ranges

Previous day
$20.73 $21.05
open $21.05 close $20.87
-$0.18 (-0.86%)
Today
$20.78 $21.28
open $20.80 now $21.21
+$0.41 (+1.97%)
Past week
$20.45 $21.10
from $20.55 now $21.21
+$0.66 (+3.21%)
Past month
$20.23 $21.45
from $20.62 now $21.21
+$0.59 (+2.86%)
This year
$19.00 $25.15
from $19.99 now $21.21
+$1.22 (+6.10%)

Price & Performance

-2.99 (-12.36%) / 6M

$19.92$21.47$23.01$24.56Apr 9Jul 10Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 15.6% away from all-time highs of $25.15
  • INVA is up 6% since the beginning of the year
  • INVA is up 22% over the past 12 months
  • INVA is up 3% over the past 1 month
  • 10% of all INVA investors are betting against INVA

INVA reads very good: price sits above one of the two key moving averages, the 12-month move is +21.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.14
Earnings momentum +321.4% Quarterly EPS growth
Quarterly change +321.4%

Valuation

P/E ratio 5.12
Enterprise value $1.2B
Beta 0.15

Balance sheet & scale

Income$357.2K
Revenue$453.8M
Cash$579.1M
Debt$269.7K
Income / Debt 1.32×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.5B

Innoviva, Inc. engages in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,179.27 +0.83%
JNJ Johnson & Johnson $261.44 +1.93%
ABBV AbbVie, Inc. $276.47 +1.49%
MRK Merck & Co., Inc. $145.60 +2.26%
RHHVF Roche Holding Ltd $434.14 +1.96%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.